Literature DB >> 7793981

Purification of human hepatic arginase and its manganese (II)-dependent and pH-dependent interconversion between active and inactive forms: a possible pH-sensing function of the enzyme on the ornithine cycle.

N J Kuhn1, S Ward, M Piponski, T W Young.   

Abstract

Purification of human liver arginase by chromatography on DEAE-Sepharose, CM-Sepharose, hydroxylapatite, and MonoS yielded protein of greater than 95% purity by sodium dodecyl sulfate-gel electrophoresis. Detailed kinetic studies of the interconversion of active and inactive forms of arginase showed the effects of metal ion addition and withdrawal, metal ion type, time, temperature, and pH. At pH 7 and 37 degrees C, removal of Mn2+ caused a first-order deactivation with half-life of 1 h. Reactivation was completed within 0.5 min (1 mM Mn2+) or 90 min (ca. 6 nM Mn2+). Activation by Mn2+ showed a hyperbolic response, with Kd for Mn2+ of about 36 nM. Mn2+ apparently displaced about 2 H+, resulting in sigmoid dependence upon concentration of OH-. Both the maximal velocity of catalysis and the Km toward arginine were markedly pH-dependent in the physiological range. The findings lead to a model where Mn2+ allosterically activates arginase by a sequential, and pH-sensitive, mechanism. The combined pH sensitivities of activation, Vmax, and Km are likely to give arginase a role in mediating the demonstrated pH control of the ornithine cycle and hence in the regulation of body pH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793981     DOI: 10.1006/abbi.1995.1338

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Endothelial arginase II responds to pharmacological inhibition by elevation in protein level.

Authors:  Karina Krotova; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Mol Cell Biochem       Date:  2010-06-19       Impact factor: 3.396

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis.

Authors:  F Esch; K I Lin; A Hills; K Zaman; J M Baraban; S Chatterjee; L Rubin; D E Ash; R R Ratan
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

Review 4.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.

Authors:  Julien H Park; Max Hogrebe; Marianne Grüneberg; Ingrid DuChesne; Ava L von der Heiden; Janine Reunert; Karl P Schlingmann; Kym M Boycott; Chandree L Beaulieu; Aziz A Mhanni; A Micheil Innes; Konstanze Hörtnagel; Saskia Biskup; Eva M Gleixner; Gerhard Kurlemann; Barbara Fiedler; Heymut Omran; Frank Rutsch; Yoshinao Wada; Konstantinos Tsiakas; René Santer; Daniel W Nebert; Stephan Rust; Thorsten Marquardt
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

6.  Expression, purification and characterization of arginase from Helicobacter pylori in its apo form.

Authors:  Jinyong Zhang; Xiaoli Zhang; Chao Wu; Dongshui Lu; Gang Guo; Xuhu Mao; Ying Zhang; Da-Cheng Wang; Defeng Li; Quanming Zou
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

7.  Unique hepatic cytosolic arginase evolved independently in ureogenic freshwater air-breathing teleost, Heteropneustes fossilis.

Authors:  Shilpee Srivastava; B K Ratha
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.